High blood flow shear stress values are associated with circulating tumor cells cluster disaggregation in a multi-channel microfluidic device.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 21 10 2020
accepted: 01 01 2021
entrez: 14 1 2021
pubmed: 15 1 2021
medline: 16 6 2021
Statut: epublish

Résumé

Metastasis represents a dynamic succession of events involving tumor cells which disseminate through the organism via the bloodstream. Circulating tumor cells (CTCs) can flow the bloodstream as single cells or as multicellular aggregates (clusters), which present a different potential to metastasize. The effects of the bloodstream-related physical constraints, such as hemodynamic wall shear stress (WSS), on CTC clusters are still unclear. Therefore, we developed, upon theoretical and CFD modeling, a new multichannel microfluidic device able to simultaneously reproduce different WSS characterizing the human circulatory system, where to analyze the correlation between SS and CTC clusters behavior. Three physiological WSS levels (i.e. 2, 5, 20 dyn/cm2) were generated, reproducing values typical of capillaries, veins and arteries. As first validation, triple-negative breast cancer cells (MDA-MB-231) were injected as single CTCs showing that higher values of WSS are correlated with a decreased viability. Next, the SS-mediated disaggregation of CTC clusters was computationally investigated in a vessels-mimicking domain. Finally, CTC clusters were injected within the three different circuits and subjected to the three different WSS, revealing that increasing WSS levels are associated with a raising clusters disaggregation after 6 hours of circulation. These results suggest that our device may represent a valid in vitro tool to carry out systematic studies on the biological significance of blood flow mechanical forces and eventually to promote new strategies for anticancer therapy.

Identifiants

pubmed: 33444361
doi: 10.1371/journal.pone.0245536
pii: PONE-D-20-32713
pmc: PMC7808575
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0245536

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nat Rev Cancer. 2013 Dec;13(12):858-70
pubmed: 24263189
APL Bioeng. 2019 Jun 20;3(2):021501
pubmed: 31263796
Cell Death Dis. 2019 Nov 4;10(11):837
pubmed: 31685811
PLoS One. 2012;7(12):e50973
pubmed: 23226552
Biomaterials. 2014 Mar;35(8):2454-61
pubmed: 24388382
J Cell Biol. 2011 Feb 7;192(3):373-82
pubmed: 21300848
Nat Rev Cancer. 2011 Jun 24;11(7):512-22
pubmed: 21701513
Polymers (Basel). 2020 Oct 24;12(11):
pubmed: 33114344
Oncotarget. 2016 Aug 2;7(31):50239-50257
pubmed: 27384484
Nat Rev Cancer. 2020 Feb;20(2):107-124
pubmed: 31780785
Cell. 2009 Nov 25;139(5):891-906
pubmed: 19931152
Cell. 2014 Aug 28;158(5):1110-1122
pubmed: 25171411
Front Oncol. 2013 Mar 05;3:44
pubmed: 23467856
Oncotarget. 2020 Mar 24;11(12):1037-1050
pubmed: 32256977
Biomicrofluidics. 2017 Mar 28;11(2):024110
pubmed: 28405259
Adv Drug Deliv Rev. 2014 Dec 15;79-80:68-78
pubmed: 25017040
Dev Cell. 2018 Apr 9;45(1):33-52.e12
pubmed: 29634935
Nat Commun. 2017 Jan 18;8:14122
pubmed: 28098159
Front Oncol. 2012 Sep 14;2:108
pubmed: 23050240
Am J Physiol Cell Physiol. 2015 May 15;308(10):C792-802
pubmed: 25788574
Sci Rep. 2016 Oct 31;6:36086
pubmed: 27796335
Front Immunol. 2019 Aug 09;10:1876
pubmed: 31447858
Lab Chip. 2008 Sep;8(9):1507-15
pubmed: 18818806
Cell. 2011 Nov 23;147(5):992-1009
pubmed: 22118458
Cancer Lett. 2017 Mar 1;388:239-248
pubmed: 27965040
Sci Rep. 2020 Jun 23;10(1):10181
pubmed: 32576883
Curr Opin Genet Dev. 2010 Feb;20(1):96-9
pubmed: 20071161
Lab Chip. 2017 Feb 14;17(4):681-690
pubmed: 28102869
J R Soc Interface. 2018 Jul;15(144):
pubmed: 29997259
Proc Natl Acad Sci U S A. 2016 May 3;113(18):4947-52
pubmed: 27091969
Cancer Cell. 2007 Jun;11(6):526-38
pubmed: 17560334
Materials (Basel). 2019 Sep 11;12(18):
pubmed: 31514390
Langmuir. 2019 Jul 30;35(30):9747-9752
pubmed: 31286768
ACS Appl Mater Interfaces. 2018 Dec 12;10(49):41978-41985
pubmed: 30479135
Free Radic Biol Med. 2018 Dec;129:46-58
pubmed: 30193891
Nat Rev Cancer. 2009 Apr;9(4):274-84
pubmed: 19308067
Am J Physiol Cell Physiol. 2014 Jan 15;306(2):C80-8
pubmed: 24133063
Sci Rep. 2017 Jan 05;7:39975
pubmed: 28054593
Biotechnol Bioeng. 2016 Oct;113(10):2286-97
pubmed: 27093435
J Biomech Eng. 2012 Dec;134(12):121003
pubmed: 23363205
ALTEX. 2020 Aug 03;38(1):82-94
pubmed: 32754773
Am J Physiol Cell Physiol. 2015 Feb 1;308(3):C229-36
pubmed: 25411332

Auteurs

Alessandra Marrella (A)

National Research Council (CNR), Institute of Electronic, Computer and Telecommunications (IEIIT), Genoa, Italy.

Arianna Fedi (A)

National Research Council (CNR), Institute of Electronic, Computer and Telecommunications (IEIIT), Genoa, Italy.
Department of Computer Science, Bioengineering, Robotics and Systems Engineering, University of Genoa, Genoa, Italy.

Gabriele Varani (G)

National Research Council (CNR), Institute of Electronic, Computer and Telecommunications (IEIIT), Genoa, Italy.

Ivan Vaccari (I)

National Research Council (CNR), Institute of Electronic, Computer and Telecommunications (IEIIT), Genoa, Italy.

Marco Fato (M)

Department of Computer Science, Bioengineering, Robotics and Systems Engineering, University of Genoa, Genoa, Italy.

Giuseppe Firpo (G)

Department of Physics, University of Genoa, Genoa, Italy.

Patrizia Guida (P)

Department of Physics, University of Genoa, Genoa, Italy.

Nicola Aceto (N)

Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Basel, Switzerland.

Silvia Scaglione (S)

National Research Council (CNR), Institute of Electronic, Computer and Telecommunications (IEIIT), Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH